JMI Syringes & Medical Devices Limited (DSE:JMISMDL)
142.80
+1.50 (1.06%)
At close: Nov 19, 2026
DSE:JMISMDL Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1,732 | 1,884 | 1,794 | 1,755 | 2,438 | |
Revenue Growth | -8.06% | 5.02% | 2.19% | -28.01% | 22.31% |
Cost of Revenue | 1,538 | 1,591 | 1,504 | 1,534 | 2,049 |
Gross Profit | 194.16 | 293.19 | 289.79 | 221.49 | 389.31 |
Selling, General & Admin | 163.97 | 156.82 | 155.77 | 141.69 | 176.37 |
Other Operating Expenses | - | 0.42 | 0.11 | 7.96 | - |
Operating Expenses | 163.97 | 157.84 | 156.49 | 150.24 | 176.97 |
Operating Income | 30.19 | 135.35 | 133.3 | 71.24 | 212.34 |
Interest Expense | -1.94 | -0.43 | -2.52 | -12.93 | -13.18 |
Interest & Investment Income | - | 1.45 | 0.27 | 1.42 | 6.89 |
Currency Exchange Gain (Loss) | - | -7.09 | -5.31 | - | -0.18 |
Other Non Operating Income (Expenses) | -71.83 | -0.17 | 5.33 | 4.73 | 1.79 |
EBT Excluding Unusual Items | -43.57 | 129.11 | 131.07 | 64.46 | 207.67 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.05 |
Pretax Income | -43.57 | 129.11 | 131.07 | 64.46 | 207.72 |
Income Tax Expense | 16.62 | 84.18 | 92.19 | 214.43 | 107.12 |
Net Income | -60.2 | 44.92 | 38.88 | -149.96 | 100.6 |
Net Income to Common | -60.2 | 44.92 | 38.88 | -149.96 | 100.6 |
Net Income Growth | - | 15.54% | - | - | 12.89% |
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 |
Shares Change | 0.14% | - | - | - | - |
EPS (Basic) | -2.00 | 1.49 | 1.29 | -4.99 | 3.35 |
EPS (Diluted) | -2.00 | 1.49 | 1.29 | -4.99 | 3.35 |
EPS Growth | - | 15.54% | - | - | 12.89% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -5.21 | 99.2 | 109.46 | 21.29 | -57.08 |
Free Cash Flow Per Share | -0.17 | 3.30 | 3.64 | 0.71 | -1.90 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 3.600 |
Dividend Growth | - | 0% | 0% | -72.22% | 63.20% |
Gross Margin | 11.21% | 15.56% | 16.16% | 12.62% | 15.97% |
Operating Margin | 1.74% | 7.18% | 7.43% | 4.06% | 8.71% |
Profit Margin | -3.48% | 2.38% | 2.17% | -8.54% | 4.13% |
Free Cash Flow Margin | -0.30% | 5.27% | 6.10% | 1.21% | -2.34% |
EBITDA | 93.4 | 201.6 | 204.06 | 145.51 | 285.59 |
EBITDA Margin | 5.39% | 10.70% | 11.38% | 8.29% | 11.71% |
D&A For EBITDA | 63.2 | 66.25 | 70.75 | 74.27 | 73.24 |
EBIT | 30.19 | 135.35 | 133.3 | 71.24 | 212.34 |
EBIT Margin | 1.74% | 7.18% | 7.43% | 4.06% | 8.71% |
Effective Tax Rate | - | 65.21% | 70.34% | 332.63% | 51.57% |
Advertising Expenses | - | 9.54 | 8.98 | 9.1 | 12.47 |